Given this evidence that PRC2 opposes Merkel cell formation, it is perhaps surprising that the PRC2 catalytic subunit EZH2 has been shown to be expressed in some MCC tumors (205–208), in which context it has been correlated with worse prognosis (206, 207). The gene discussed is EZH2; the disease is Merkel cell skin cancer.